News from palatin technologies, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 18, 2014, 07:30 ET

Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Nov 13, 2014, 16:30 ET

Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2015 Results

 Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its first quarter, fiscal year 2015 operating results on Tuesday, November 18, 2014...

Nov 04, 2014, 09:05 ET

Survey Reveals Low Sexual Desire Disrupts Relationships

Nearly one in two non-menopausal women ages 30 to 50 say they have experienced low sexual desire at some point in their lives, and many of these...

Oct 08, 2014, 07:30 ET

Palatin Technologies To Present At The 13th Annual BIO Investor Forum

 Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting today at the 13th Annual BIO Investor Forum at 11:00 a.m....

Sep 09, 2014, 07:30 ET

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2014 Results

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Sep 04, 2014, 16:58 ET

Palatin Technologies, Inc. To Report Fourth Quarter and Fiscal Year 2014 Results

 Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its fourth quarter, fiscal year 2014 operating results on Tuesday, September 9, 2014...

Sep 03, 2014, 02:00 ET

Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter

Palatin Technologies, Inc. (NYSE MKT: PTN; hereinafter: "Palatin") and Gedeon Richter Plc. (hereinafter: "Richter") announced that they have...

Jul 09, 2014, 07:30 ET

Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Jun 27, 2014, 07:30 ET

Palatin Technologies to Join Russell Microcap Index

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Jun 10, 2014, 07:30 ET

Palatin Technologies Announces Notification of Patent Allowance On Next Generation Melanocortin Receptor-Specific Peptides

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

May 20, 2014, 09:00 ET

New Survey Reveals That Low Sexual Desire Disrupts Relationships

Nearly one in two non-menopausal women ages 30 to 50 say they have experienced low sexual desire at some point in their lives, and many of these...

May 13, 2014, 07:30 ET

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on May 13, 2014

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

May 09, 2014, 16:29 ET

Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2014 Results

 Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its third quarter, fiscal year 2014 operating results on Tuesday, May 13, 2014 before...

May 06, 2014, 17:18 ET

Palatin Technologies Presents at the American Psychiatric Association (APA)

 Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that data from a 12-week placebo-controlled dose-ranging study using...

May 01, 2014, 07:30 ET

Palatin Technologies Announces Option Exercise by Specialty Pharmaceutical Company to License Bremelanotide in Europe

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Apr 29, 2014, 07:30 ET

Palatin Technologies Presents at the Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG)

 Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that data from a 12-week placebo-controlled dose-ranging study using...

Mar 31, 2014, 16:15 ET

Palatin Technologies Announces Option Extension for License to Bremelanotide in Europe

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Mar 06, 2014, 07:30 ET

Palatin Technologies To Present At The 26Th Annual ROTH Conference

Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the 26th Annual ROTH Conference on Tuesday, March 11, 2014, at...

Feb 24, 2014, 07:30 ET

Palatin Technologies Presents Positive New Data Analyses Demonstrating Efficacy of Bremelanotide in Female Hypoactive Sexual Desire Disorder

Palatin Technologies, Inc. (NYSE MKT: PTN) presented new analyses from its Phase 2b clinical trial of bremelanotide, which demonstrated...

Feb 18, 2014, 07:30 ET

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on February 18, 2014

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...